Korecyte Bio
We provide the tools to make cell therapy safer and more effective for treating solid tumours and beyond.
2 employees · est. 2023 · London, United Kingdom
Celyad Oncology is the older company (2007 vs 2023); Celyad Oncology is the larger of the two.
Side-by-Side Comparison
| Metric | Celyad Oncology | Korecyte Bio |
|---|---|---|
| Founded | ||
| Founded | 2007 older | 2023 |
| Headquarters | ||
| Headquarters | Belgium | London, United Kingdom |
| Employees | ||
| Employees | 19 larger | 2 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Medical Devices | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Not tracked yet |
| Total Funding | ||
| Total Funding | $135.80M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 9 | Not tracked yet |
| Services | ||
| Services | Development of CAR T-cell candidates, Biotechnology innovation, Therapeutics development | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare providers, Oncologists, Cancer research facilities, Pharmaceutical companies | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cell Therapy, Intellectual Property, Immuno-Oncology, Cardiology, CAR-T NKR-2, C-Cure, CYAD-01, CYAD-02, CYAD-03, CAR T-cells, Immunotherapy, NKG2D, ShRNA Multiplex | Biotech Startup, Cell Therapy, Cancer Treatment, CAR-T Immunotherapy, Solid Tumors, Netherlands, United Kingdom, Next-Generation Therapy, International Biotech, CAR-NK Therapy, CAR-Tregs, Immunotherapies, Clinical Research, Healthcare Innovation, Cancer Immunotherapy |
| Website | ||
| Website | celyad.com | korecyte.com |
About Celyad Oncology
Celyad Oncology, founded in 2007, is a biotechnology company headquartered in Mont Saint-Guibert, Belgium. The company is dedicated to leveraging its intellectual property to facilitate advancements in the fields of Biotechnology, Health and Wellness, and Medical Devices. In its recent financial ac...
About Korecyte Bio
Korecyte Bio, a London-based cell therapy startup founded in 2023, is dedicated to advancing the field of cell therapy. The company's mission is to enhance the safety and efficacy of cell therapy for treating solid tumors and beyond. With a focus on next-generation cell therapy tools, Korecyte Bio a...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Celyad Oncology and Korecyte Bio — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Celyad Oncology and Korecyte Bio — by email.
Frequently Asked Questions
Compare Celyad Oncology with someone else
Start typing a company name or domain.